Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer
Article in Translational Oncology (March 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Translational Oncology (March 2024)
Article in Experimental and Therapeutic Medicine (March 2024)
Article in Frontiers in Immunology (August 2023)